Fredika M. Robertson - Publications

Affiliations: 
Ohio State University, Columbus, Columbus, OH 
Area:
Oncology, Pathology, Biochemistry

78/158 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Morlacchi P, Robertson FM, Klostergaard J, McMurray JS. Targeting SH2 domains in breast cancer. Future Medicinal Chemistry. 6: 1909-26. PMID 25495984 DOI: 10.4155/Fmc.14.120  0.359
2014 Bertucci F, Ueno NT, Finetti P, Vermeulen P, Lucci A, Robertson FM, Marsan M, Iwamoto T, Krishnamurthy S, Masuda H, Van Dam P, Woodward WA, Cristofanilli M, Reuben JM, Dirix L, et al. Gene expression profiles of inflammatory breast cancer: correlation with response to neoadjuvant chemotherapy and metastasis-free survival. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 25: 358-65. PMID 24299959 DOI: 10.1093/Annonc/Mdt496  0.354
2014 Fernandez SV, Robertson FM, Addya S, Mu Z, Cristofanilli M. Abstract 4988: Clues for targeted therapies in inflammatory breast cancer (IBC) Cancer Research. 74: 4988-4988. DOI: 10.1158/1538-7445.Am2014-4988  0.43
2013 Robertson FM, Chu K, Boley KM, Ye Z, Liu H, Wright MC, Moraes R, Zhang X, Green TL, Barsky SH, Heise C, Cristofanilli M. The class I HDAC inhibitor Romidepsin targets inflammatory breast cancer tumor emboli and synergizes with paclitaxel to inhibit metastasis. Journal of Experimental Therapeutics & Oncology. 10: 219-33. PMID 24416998  0.366
2013 Robertson FM, Petricoin Iii EF, Van Laere SJ, Bertucci F, Chu K, Fernandez SV, Mu Z, Alpaugh K, Pei J, Circo R, Wulfkuhle J, Ye Z, Boley KM, Liu H, Moraes R, et al. Presence of anaplastic lymphoma kinase in inflammatory breast cancer. Springerplus. 2: 497. PMID 24102046 DOI: 10.1186/2193-1801-2-497  0.408
2013 Fernandez SV, Robertson FM, Pei J, Aburto-Chumpitaz L, Mu Z, Chu K, Alpaugh RK, Huang Y, Cao Y, Ye Z, Cai KQ, Boley KM, Klein-Szanto AJ, Devarajan K, Addya S, et al. Inflammatory breast cancer (IBC): clues for targeted therapies. Breast Cancer Research and Treatment. 140: 23-33. PMID 23784380 DOI: 10.1007/S10549-013-2600-4  0.398
2013 Zhang EY, Cristofanilli M, Robertson F, Reuben JM, Mu Z, Beavis RC, Im H, Snyder M, Hofree M, Ideker T, Omenn GS, Fanayan S, Jeong SK, Paik YK, Zhang AF, et al. Genome wide proteomics of ERBB2 and EGFR and other oncogenic pathways in inflammatory breast cancer. Journal of Proteome Research. 12: 2805-17. PMID 23647160 DOI: 10.1021/Pr4001527  0.323
2013 Chu K, Boley KM, Moraes R, Barsky SH, Robertson FM. The paradox of E-cadherin: role in response to hypoxia in the tumor microenvironment and regulation of energy metabolism. Oncotarget. 4: 446-62. PMID 23530113 DOI: 10.18632/Oncotarget.872  0.416
2013 Van Laere SJ, Ueno NT, Finetti P, Vermeulen P, Lucci A, Robertson FM, Marsan M, Iwamoto T, Krishnamurthy S, Masuda H, van Dam P, Woodward WA, Viens P, Cristofanilli M, Birnbaum D, et al. Uncovering the molecular secrets of inflammatory breast cancer biology: an integrated analysis of three distinct affymetrix gene expression datasets. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 4685-96. PMID 23396049 DOI: 10.1158/1078-0432.Ccr-12-2549  0.381
2013 Chu K, Green T, Boley K, Cristofanilli M, Robertson F. Abstract P6-12-14: Histone deacetylase inhibitor suberoylanilide hydroxamic acid targets breast cancer stem cells and inhibits metastasis Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P6-12-14  0.43
2013 Mu Z, Brown M, Fernandez S, Robertson F, Cristofanilli M. Abstract P3-01-05: Metabolomic analysis of breast cancer cell lines: Clues to the metabolic fingerprint of inflammatory breast cancer Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P3-01-05  0.365
2013 Laere SV, Marsan M, Vermeulen P, Viens P, Barsky S, Cristofanilli M, Dirix L, Bertucci F, Robertson F. Abstract P2-05-04: Comparative expression profiling of patient samples and preclinical models of inflammatory breast cancer reveals gene signatures of epithelial plasticity and suppression of TGFb signaling Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P2-05-04  0.398
2012 Debeb BG, Cohen EN, Boley K, Freiter EM, Li L, Robertson FM, Reuben JM, Cristofanilli M, Buchholz TA, Woodward WA. Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells. Breast Cancer Research and Treatment. 134: 495-510. PMID 22547109 DOI: 10.1007/S10549-012-2075-8  0.387
2012 Fernandez SV, Mu Z, Aburto L, Dong X, Chu K, Boley K, Berditchevski F, Robertson F, Cristofanilli M. Abstract 5342: FC-IBC-02: A newin vitro-in vivomodel of inflammatory breast cancer (IBC) Cancer Research. 72: 5342-5342. DOI: 10.1158/1538-7445.Am2012-5342  0.418
2012 Liu H, Chu K, Ochoa A, Ye Z, Zhang X, Jin J, Wright M, Barsky S, Cristofanilli M, Robertson F. Abstract P6-10-04: The Presence of Anaplastic Lymphoma Kinase Recapitulates Formation of Breast Tumor Emboli with Encircling Lymphovasculogenesis Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P6-10-04  0.447
2012 Chu K, Boley K, Cristofanilli M, Robertson F. Abstract P5-04-05: E-Cadherin is Required for In Vivo Growth of Inflammatory Breast Cancer: Importance of Mesenchymal-Epithelial Transition (MET) and Role of HIF1α Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P5-04-05  0.416
2012 Robertson F, Hibbs S, Boley K, Chu K, Ye Z, Wright M, Liu H, Luo A, Cristofanilli M, Wemhoff G. Abstract P4-06-03: Zinc Finger Nuclease Genome Engineering Reveal Multiple Functions of Secretory Leukocyte Peptidase Inhibitor in Regulating Pleuripotency of Cancer Stem Cells in Inflammatory Breast Cancer Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P4-06-03  0.455
2012 Robertson FM, Cristofanilli M. New therapeutic targets in inflammatory breast cancer Current Breast Cancer Reports. 4: 264-270. DOI: 10.1007/S12609-012-0087-3  0.34
2012 Robertson FM, Chu K, Circo R, Wulfkuhle J, Liotta L, Luo AZ, Boley KM, Freiter EM, Liu H, Mandal PK, Mc Murray JS, Cristofanilli M, Petricoin EF. Inflammatory mediators as therapeutic targets for inflammatory breast cancer Inflammatory Breast Cancer: An Update. 185-205. DOI: 10.1007/978-94-007-3907-9_16  0.319
2011 Van Laere SJ, Ueno NT, Finetti P, Vermeulen PB, Lucci A, Birnbaum D, Robertson F, Iwamoto T, van Dam PA, Woodward WA, Viens P, Dirix LY, Reuben JM, Bertucci F. An integrated analysis of three distinct IBC/non-IBC affymetrix gene expression data sets to study the transcriptional heterogeneity both between IBC and non-IBC and within IBC. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 10571. PMID 28021912 DOI: 10.1200/Jco.2011.29.15_Suppl.10571  0.353
2011 Mandal PK, Freiter EM, Bagsby AL, Robertson FM, McMurray JS. Efficient synthesis of apricoxib, CS-706, a selective cyclooxygenase-2 inhibitor, and evaluation of inhibition of prostaglandin E2 production in inflammatory breast cancer cells. Bioorganic & Medicinal Chemistry Letters. 21: 6071-3. PMID 21903394 DOI: 10.1016/J.Bmcl.2011.08.050  0.359
2011 Robertson FM, Cristofanilli M. A global approach to inflammatory breast cancer. Future Oncology (London, England). 7: 25-30. PMID 21174535 DOI: 10.2217/Fon.10.177  0.339
2011 Iwamoto T, Bianchini G, Qi Y, Cristofanilli M, Lucci A, Woodward WA, Reuben JM, Matsuoka J, Gong Y, Krishnamurthy S, Valero V, Hortobagyi GN, Robertson F, Symmans WF, Pusztai L, et al. Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancer Breast Cancer Research and Treatment. 125: 785-795. PMID 21153052 DOI: 10.1007/S10549-010-1280-6  0.383
2011 Dawood S, Merajver SD, Viens P, Vermeulen PB, Swain SM, Buchholz TA, Dirix LY, Levine PH, Lucci A, Krishnamurthy S, Robertson FM, Woodward WA, Yang WT, Ueno NT, Cristofanilli M. International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 22: 515-23. PMID 20603440 DOI: 10.1093/Annonc/Mdq345  0.368
2011 Debeb BG, Lacerda L, Xu W, Robertson F, Ueno NT, Lucci A, Reuben JM, Buchholz TA, Woodward WA. Abstract 3340: Expansion of human breast cancer stem /progenitor cell subpopulation through histone deacetylase inhibitors Cancer Research. 71: 3340-3340. DOI: 10.1158/1538-7445.Am2011-3340  0.354
2011 Laere SJV, Ueno N, Finetti P, Vermeulen PB, Lucci A, Birnbaum D, Robertson F, Iwamoto T, Dam PV, Woodward W, Viens P, Dirix LY, Reuben JR, Bertucci F. Abstract 328: An integrated analysis of three distinct IBC/non-IBC Affymetrix gene expression data sets to study the transcriptional heterogeneity both between IBC and non-IBC and within IBC Cancer Research. 71: 328-328. DOI: 10.1158/1538-7445.Am2011-328  0.324
2011 Robertson FM. Abstract PR-4: Gene amplification of anaplastic lymphoma kinase in inflammatory breast cancer. Molecular Cancer Therapeutics. 10. DOI: 10.1158/1535-7163.Targ-11-Pr-4  0.424
2011 McMurray JS, Klostergaard J, Robertson FM, Mandal PK, Auzenne EJ, Liao WS. Abstract B8: Selective inhibition of Stat3 Tyr705 phosphorylation inhibits angiogenesis in breast cancer xenografts. Molecular Cancer Therapeutics. 10. DOI: 10.1158/1535-7163.Targ-11-B8  0.365
2011 Laere SV, Ueno N, Finetti P, Vermeulen P, Lucci A, Birnbaum D, Robertson F, Dam Pv, Woodward W, Viens P, Dirix L, Reuben J, Iwamoto T, Cristofanilli M, Bertucci F. PD03-01: An Integrated Analysis of Three Distinct IBC/nIBC Affymetrix Gene Expression Data Sets Further Unveils the Molecular Biology of IBC. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-Pd03-01  0.335
2011 Robertson F, Ye Z, Chu K, Luo A, Wright M, Jin J, Barsky S, Cristofanilli M, Krishnamurthy S. P4-09-08: Secretory Leukocyte Protease Inhibitor as a Differential Diagnostic Biomarker of Tumor Emboli in Inflammatory Breast Cancer. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P4-09-08  0.441
2011 Chu K, Mu Z, Alpaugh K, Fernandez S, Freiter E, Wu H, Zook M, Barsky S, Cristofanilli M, Robertson F. P4-03-06: Development and Comparative Characterization of Metastasis in Newly Developed Pre-Clinical Models of Inflammatory Breast Cancer. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P4-03-06  0.422
2011 Liu H, Luo A, Mu Z, Chu K, Ye Z, Alpaugh R, Fernandez S, Boley K, Jin J, Wright M, Cristofanilli M, Robertson F. P2-05-04: Mapping the Specific Gene Families Activated in the Lymphangiogenesis and Vasculogenic Mimicry Exhibited by Inflammatory Breast Cancer. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P2-05-04  0.432
2011 Chu K, Boley K, Luo A, Ye Z, Wright M, Freiter E, Robertson F. P1-02-03: The Reciprocal Roles of E-Cadherin and ZEB1 Demonstrate the Mesenchymal-Epithelial Transition as a Primary Characteristic of Inflammatory Breast Cancer. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P1-02-03  0.431
2010 Robertson FM, Bondy M, Yang W, Yamauchi H, Wiggins S, Kamrudin S, Krishnamurthy S, Le-Petross H, Bidaut L, Player AN, Barsky SH, Woodward WA, Buchholz T, Lucci A, Ueno NT, et al. Inflammatory breast cancer: the disease, the biology, the treatment. Ca: a Cancer Journal For Clinicians. 60: 351-75. PMID 20959401 DOI: 10.3322/Caac.20082  0.335
2010 Robertson FM, Ogasawara MA, Ye Z, Chu K, Pickei R, Debeb BG, Woodward WA, Hittelman WN, Cristofanilli M, Barsky SH. Imaging and analysis of 3D tumor spheroids enriched for a cancer stem cell phenotype. Journal of Biomolecular Screening. 15: 820-9. PMID 20639504 DOI: 10.1177/1087057110376541  0.384
2010 Debeb BG, Zhang X, Krishnamurthy S, Gao H, Cohen E, Li L, Rodriguez AA, Landis MD, Lucci A, Ueno NT, Robertson F, Xu W, Lacerda L, Buchholz TA, Cristofanilli M, et al. Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells. Molecular Cancer. 9: 180. PMID 20615238 DOI: 10.1186/1476-4598-9-180  0.313
2010 Robertson FM, Simeone AM, Lucci A, McMurray JS, Ghosh S, Cristofanilli M. Differential regulation of the aggressive phenotype of inflammatory breast cancer cells by prostanoid receptors EP3 and EP4. Cancer. 116: 2806-14. PMID 20503412 DOI: 10.1002/Cncr.25167  0.403
2010 Robertson FM, Woodward WA, Pickei R, Ye Z, Bornmann W, Pal A, Peng Z, Hall CS, Cristofanilli M. Suberoylanilide hydroxamic acid blocks self-renewal and homotypic aggregation of inflammatory breast cancer spheroids. Cancer. 116: 2760-7. PMID 20503408 DOI: 10.1002/Cncr.25176  0.432
2010 Thudi NK, Mandal PK, McMurray JS, Robertson FM. Abstract 653: Stat3 as a molecular signature and therapeutic target for inflammatory breast cancer Cancer Research. 70: 653-653. DOI: 10.1158/1538-7445.Am10-653  0.441
2010 Mandal PK, Liao WS, Gao F, Robertson FM, Thudi NK, Ekmekcioglu S, Chattopadhyay C, Ren Z, Chen X, Lu Z, Bast RC, Ramesh R, McMurray JS. Abstract 2527: Potent, highly selective peptidomimetic prodrugs targeting the SH2 domain of Stat3 decrease vasculogenic mimicry, invasion, and anchorage independent growth of cancer cells Cancer Research. 70: 2527-2527. DOI: 10.1158/1538-7445.Am10-2527  0.381
2010 Chu K, Player AN, Pickei R, Robertson FM. Abstract 1465: Histone deacetylase inhibitor suberoylanilide hydroxamic acid blocks epithelial-mesenchymal transition exhibited by Tera-2 embryonal carcinoma cells with a stem cell phenotype Cancer Research. 70: 1465-1465. DOI: 10.1158/1538-7445.Am10-1465  0.412
2010 Robertson F, Player A, Chu K, Pickei R, Ye Z, Krishnamurthy S, Liu C, Liu X, Cristofanilli M, Barsky S. Abstract P6-04-13: Gene and microRNA Signatures of the Mesenchymal Epithelial Transition in Pre-Clinical Models of Inflammatory Breast Cancer Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-P6-04-13  0.439
2010 Debeb B, Xu W, Lacerda L, Hortobagyi G, Robertson F, Ueno N, Lucci A, Reuben J, Buchholz T, Woodward W. Abstract P4-04-05: Histone Deacetylase Inhibitors Increase Markers of the Dedifferentiated Cancer Stem Cell Phenotype in Human Breast Cancer Cells Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-P4-04-05  0.35
2009 Tanaka T, Decuzzi P, Cristofanilli M, Sakamoto JH, Tasciotti E, Robertson FM, Ferrari M. Nanotechnology for breast cancer therapy. Biomedical Microdevices. 11: 49-63. PMID 18663578 DOI: 10.1007/S10544-008-9209-0  0.341
2009 Tasciotti E, Bhavane R, Godin-Vilentchouk B, Serda R, Liu X, Robertson F, Ferrari M. A multistage nanodelivery system for therapeutic applications and medical imaging: in vivo biodistribution and efficacy study in a murine orthotopic breast cancer model. Cancer Research. 69: 2160. DOI: 10.1158/0008-5472.Sabcs-2160  0.331
2009 Robertson F, Simeone A, Lucci A, Woodward W, Reuben J, Ueno N, Cristofanilli M. Role of the prostaglandin receptor EP3 in regulating vasculogenic mimicry of inflammatory breast cancer. Cancer Research. 69: 2127. DOI: 10.1158/0008-5472.Sabcs-2127  0.454
2009 Ueno N, Kazansky A, LaFortune T, Lucci A, Krishnamurthy S, Hung M, Hortobagyi G, Woodward W, Reuben J, Robertson F, Cristofanilli M, Zhang D. Suppression of mesenchymal phenotype in inflammatory breast cancer by EGFR tyrosine kinase inhibitor erlotinib: a novel approach to suppressing metastasis. Cancer Research. 69: 2042. DOI: 10.1158/0008-5472.Sabcs-2042  0.345
2009 Hall C, Debeb B, Xu W, Ueno N, Reuben J, Robertson F, Lucci A, Buchholz T, Hortobagyi G, Cristofanilli M, Woodward W. Novel inflammatory breast cancer cell line, MDA-IBC-1 expresses and secretes WISP3, a putative tumor suppressor in inflammatory breast cancer. Cancer Research. 69: 1051. DOI: 10.1158/0008-5472.Sabcs-1051  0.402
2009 Li C, Lee B, Woodward W, Ueno N, Robertson F, Reuben J, Cristofanilli M. p53 Mutation in Inflammatory Breast Cancer Cell Lines. Cancer Research. 69: 3161-3161. DOI: 10.1158/0008-5472.Sabcs-09-3161  0.383
2009 Robertson F, Woodward W, Bornmann W, Player A, Ye Z, Cristofanilli M. The pan-HDAC Inhibitor Suberoylanilide Hydroxamic Acid Targets Self Renewal of Breast Cancer Stem Cells. Cancer Research. 69: 3141-3141. DOI: 10.1158/0008-5472.Sabcs-09-3141  0.436
2008 Robertson FM, Simeone AM, Mazumdar A, Shah AH, McMurray JS, Ghosh S, Cristofanilli M. Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cells. Journal of Experimental Therapeutics & Oncology. 7: 299-312. PMID 19227010  0.305
2007 Robertson FM, Mallery SR, Bergdall-Costell VK, Cheng M, Pei P, Prosperi JR, Ferrari M. Cyclooxygenase-2 directly induces MCF-7 breast tumor cells to develop into exponentially growing, highly angiogenic and regionally invasive human ductal carcinoma xenografts. Anticancer Research. 27: 719-27. PMID 17465194  0.316
2006 Prosperi JR, Robertson FM. Cyclooxygenase-2 directly regulates gene expression of P450 Cyp19 aromatase promoter regions pII, pI.3 and pI.7 and estradiol production in human breast tumor cells. Prostaglandins & Other Lipid Mediators. 81: 55-70. PMID 16997132 DOI: 10.1016/J.Prostaglandins.2006.07.003  0.456
2006 Robertson FM, Ming-Cheng Cheng M, Prosperi JR, Gaspari M, Terracciano R, Green-Church KB, Vandre DD, Cuda G, Ferrari M. Nanochips for mining the serum and tumor proteome: novel nanochips for sensitive and reproducible identification of the low molecular weight proteome in serum isolated from mice bearing highly invasive human breast tumor xenografts Nanomedicine: Nanotechnology, Biology and Medicine. 2: 295. DOI: 10.1016/J.Nano.2006.10.084  0.365
2004 Prosperi JR, Mallery SR, Kigerl KA, Erfurt AA, Robertson FM. Invasive and angiogenic phenotype of MCF-7 human breast tumor cells expressing human cyclooxygenase-2. Prostaglandins & Other Lipid Mediators. 73: 249-64. PMID 15290792 DOI: 10.1016/J.Prostaglandins.2004.03.004  0.43
2004 Mallery SR, Pei P, Landwehr DJ, Clark CM, Bradburn JE, Ness GM, Robertson FM. Implications for oxidative and nitrative stress in the pathogenesis of AIDS-related Kaposi's sarcoma. Carcinogenesis. 25: 597-603. PMID 14656937 DOI: 10.1093/Carcin/Bgh042  0.341
2003 Mallery SR, Morse MA, Wilson RF, Pei P, Ness GM, Bradburn JE, Renner RJ, Schuller DE, Robertson FM. AIDS-related Kaposi's sarcoma cells rapidly internalize endostatin, which co-localizes to tropomysin microfilaments and inhibits cytokine-mediated migration and invasion. Journal of Cellular Biochemistry. 89: 133-43. PMID 12682914 DOI: 10.1002/Jcb.10489  0.394
2002 Wilgus TA, Parrett ML, Ross MS, Tober KL, Robertson FM, Oberyszyn TM. Inhibition of ultraviolet light B-induced cutaneous inflammation by a specific cyclooxygenase-2 inhibitor. Advances in Experimental Medicine and Biology. 507: 85-92. PMID 12664569 DOI: 10.1007/978-1-4615-0193-0_14  0.749
2001 Oberyszyn TM, Robertson FM, Tober KL, Ross MS, Parrett ML, Wilgus TA, Iyer S, Woo J, Buelow R. Inhibition of cutaneous UV light-induced tumor necrosis factor-alpha protein production by Allotrap 1258, a novel immunomodulatory peptide. Photochemistry and Photobiology. 73: 184-90. PMID 11272733 DOI: 10.1562/0031-8655(2001)073<0184:Ioculi>2.0.Co;2  0.734
1999 Parrett ML, Abou-Issa HM, Alshafie G, Ross MS, Harris RE, Robertson FM. Comparative ability of ibuprofen and N-(4-hydroxyphenyl)retinamide to inhibit development of rat mammary adenocarcinomas associated with differential inhibition of gene expression of cyclooxygenase isoforms. Anticancer Research. 19: 5079-85. PMID 10697514  0.785
1999 Alshafie GA, Harris RE, Robertson FM, Parrett ML, Ross M, Abou-Issa H. Comparative chemopreventive activity of ibuprofen and N-(4-hydroxyphenyl) retinamide against the development and growth of rat mammary adenocarcinomas. Anticancer Research. 19: 3031-6. PMID 10652588  0.766
1999 Harris RE, Robertson FM, Abou-Issa HM, Farrar WB, Brueggemeier R. Genetic induction and upregulation of cyclooxygenase (COX) and aromatase (CYP19): an extension of the dietary fat hypothesis of breast cancer. Medical Hypotheses. 52: 291-2. PMID 10465664 DOI: 10.1054/Mehy.1998.0009  0.461
1999 Brueggemeier RW, Quinn AL, Parrett ML, Joarder FS, Harris RE, Robertson FM. Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens. Cancer Letters. 140: 27-35. PMID 10403538 DOI: 10.1016/S0304-3835(99)00050-6  0.763
1998 Tober KL, Cannon RE, Spalding JW, Oberyszyn TM, Parrett ML, Rackoff AI, Oberyszyn AS, Tennant RW, Robertson FM. Comparative expression of novel vascular endothelial growth factor/vascular permeability factor transcripts in skin, papillomas, and carcinomas of v-Ha-ras Tg.AC transgenic mice and FVB/N mice. Biochemical and Biophysical Research Communications. 247: 644-53. PMID 9647747 DOI: 10.1006/Bbrc.1998.8787  0.725
1998 Oberyszyn TM, Tober KL, Ross MS, Robertson FM. Inhibitory effects of pentoxifylline on ultraviolet B light-induced cutaneous inflammation. Molecular Carcinogenesis. 22: 16-25. PMID 9609097 DOI: 10.1002/(Sici)1098-2744(199805)22:1<16::Aid-Mc3>3.0.Co;2-J  0.714
1998 Oberyszyn TM, Conti CJ, Ross MS, Oberyszyn AS, Tober KL, Rackoff AI, Robertson FM. Beta2 integrin/ICAM-1 adhesion molecule interactions in cutaneous inflammation and tumor promotion. Carcinogenesis. 19: 445-55. PMID 9525279 DOI: 10.1093/Carcin/19.3.445  0.69
1998 Robertson FM, Parrett ML, Joarder FS, Ross M, Abou-Issa HM, Alshafie G, Harris RE. Ibuprofen-induced inhibition of cyclooxygenase isoform gene expression and regression of rat mammary carcinomas. Cancer Letters. 122: 165-75. PMID 9464506 DOI: 10.1016/S0304-3835(97)00387-X  0.77
1997 Joarder FS, Abou-Issa H, Robertson FM, Parrett ML, Alshafie G, Harris RE. Growth arrest of DMBA-induced mammary carcinogenesis with ibuprofen treatment in female Sprague-Dawley rats Oncology Reports. 4: 1271-1273. DOI: 10.3892/Or.4.6.1271  0.772
1997 Parkett ML, Harris RE, Joarder FS, Ross MS, Clausen KP, Robertson FM. Cyclooxygenase-2 gene expression in human breast cancer International Journal of Oncology. 10: 503-507. DOI: 10.3892/Ijo.10.3.503  0.458
1996 Ariza ME, Oberyszyn AS, Robertson FM, Williams MV. Mutagenic potential of peripheral blood leukocytes: in vivo exposure to the carcinogen 7,12-dimethylbenz[a]anthracene, and the tumor promoter 12-O-tetradecanoylphorbol acetate followed by in vitro co-culture with AS52 cells. Cancer Letters. 106: 9-16. PMID 8827041 DOI: 10.1016/0304-3835(96)04290-5  0.343
1996 Robertson FM, Long BW, Tober KL, Ross MS, Oberyszyn TM. Gene expression and cellular sources of inducible nitric oxide synthase during tumor promotion. Carcinogenesis. 17: 2053-9. PMID 8824534 DOI: 10.1093/Carcin/17.9.2053  0.721
1996 Robertson FM, Ross MS, Tober KL, Long BW, Oberyszyn TM. Inhibition of pro-inflammatory cytokine gene expression and papilloma growth during murine multistage carcinogenesis by pentoxifylline. Carcinogenesis. 17: 1719-28. PMID 8761432 DOI: 10.1093/Carcin/17.8.1719  0.73
1996 Choban PS, Mcknight T, Flancbaum L, Sabourin CL, Bijur GN, Boros LG, Marley J, Burge JC, Robertson FM. Characterization of a murine model of acute lung injury (ALI): a prominent role for interleukin-1. Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research. 9: 95-109. PMID 8725550 DOI: 10.3109/08941939609012463  0.317
1996 Wang QS, Sabourin CL, Bijur GN, Robertson FM, Stoner GD. Alterations in transforming growth factor-alpha and epidermal growth factor receptor expression during rat esophageal tumorigenesis. Molecular Carcinogenesis. 15: 144-53. PMID 8599581 DOI: 10.1002/(Sici)1098-2744(199602)15:2<144::Aid-Mc7>3.0.Co;2-J  0.347
1995 Robertson FM, Pellegrini AE, Ross MS, Oberyszyn AS, Boros LG, Bijur GN, Sabourin CL, Oberyszyn TM. Interleukin-1alpha gene expression during wound healing. Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society. 3: 473-84. PMID 17147659 DOI: 10.1046/J.1524-475X.1995.30412.X  0.348
1995 Nill MR, Oberyszyn TM, Ross MS, Oberyszyn AS, Robertson FM. Temporal sequence of pulmonary cytokine gene expression in response to endotoxin in C3H/HeN endotoxin-sensitive and C3H/HeJ endotoxin-resistant mice. Journal of Leukocyte Biology. 58: 563-74. PMID 7595058 DOI: 10.1002/Jlb.58.5.563  0.345
1994 Robertson FM, Bijur GN, Oberyszyn AS, Pellegrini AE, Boros LG, Sabourin CL, Oberyszyn TM. Granulocyte-macrophage colony stimulating factor gene expression and function during tumor promotion. Carcinogenesis. 15: 1017-29. PMID 8200063 DOI: 10.1093/Carcin/15.5.1017  0.437
1993 Oberyszyn TM, Sabourin CL, Bijur GN, Oberyszyn AS, Boros LG, Robertson FM. Interleukin-1 alpha gene expression and localization of interleukin-1 alpha protein during tumor promotion. Molecular Carcinogenesis. 7: 238-48. PMID 8352883 DOI: 10.1002/Mc.2940070406  0.338
Low-probability matches (unlikely to be authored by this person)
2012 Auzenne EJ, Klostergaard J, Mandal PK, Liao WS, Lu Z, Gao F, Bast RC, Robertson FM, McMurray JS. A phosphopeptide mimetic prodrug targeting the SH2 domain of Stat3 inhibits tumor growth and angiogenesis. Journal of Experimental Therapeutics & Oncology. 10: 155-62. PMID 23350355  0.299
2010 Debeb BG, Xu W, Mok H, Li L, Robertson F, Ueno NT, Reuben J, Lucci A, Cristofanilli M, Woodward WA. Differential radiosensitizing effect of valproic acid in differentiation versus self-renewal promoting culture conditions. International Journal of Radiation Oncology, Biology, Physics. 76: 889-95. PMID 20159363 DOI: 10.1016/J.Ijrobp.2009.09.052  0.296
2003 Shokolenko IN, Alexeyev MF, Robertson FM, LeDoux SP, Wilson GL. The expression of Exonuclease III from E. coli in mitochondria of breast cancer cells diminishes mitochondrial DNA repair capacity and cell survival after oxidative stress. Dna Repair. 2: 471-82. PMID 12713808 DOI: 10.1016/S1568-7864(03)00019-3  0.295
1997 D'Ambrosio SM, Oberyszyn TM, Brady T, Ross MS, Robertson FM. Sensitivity of human hepatocytes in culture to reactive nitrogen intermediates. Biochemical and Biophysical Research Communications. 233: 545-9. PMID 9144574 DOI: 10.1006/Bbrc.1997.6472  0.292
2013 Ye Y, Tian H, Lange AR, Yearsley K, Robertson FM, Barsky SH. The genesis and unique properties of the lymphovascular tumor embolus are because of calpain-regulated proteolysis of E-cadherin. Oncogene. 32: 1702-13. PMID 22580607 DOI: 10.1038/Onc.2012.180  0.291
2012 Ye Y, Gao JX, Tian H, Yearsley K, Lange AR, Robertson FM, Barsky SH. Early to intermediate steps of tumor embolic formation involve specific proteolytic processing of E-cadherin regulated by Rab7. Molecular Cancer Research : McR. 10: 713-26. PMID 22638108 DOI: 10.1158/1541-7786.Mcr-12-0009  0.291
2009 Roberts RA, Laskin DL, Smith CV, Robertson FM, Allen EM, Doorn JA, Slikker W. Nitrative and oxidative stress in toxicology and disease. Toxicological Sciences : An Official Journal of the Society of Toxicology. 112: 4-16. PMID 19656995 DOI: 10.1093/Toxsci/Kfp179  0.291
2012 McMurray JS, Mandal PK, Liao WS, Klostergaard J, Robertson FM. The consequences of selective inhibition of signal transducer and activator of transcription 3 (STAT3) tyrosine705 phosphorylation by phosphopeptide mimetic prodrugs targeting the Src homology 2 (SH2) domain. Jak-Stat. 1: 263-347. PMID 24058783 DOI: 10.4161/jkst.22682  0.288
2001 D'Ambrosio SM, Gibson-D'Ambrosio RE, Brady T, Oberyszyn AS, Robertson FM. Mechanisms of nitric oxide-induced cytotoxicity in normal human hepatocytes. Environmental and Molecular Mutagenesis. 37: 46-54. PMID 11170241 DOI: 10.1002/1098-2280(2001)37:1<46::Aid-Em1005>3.0.Co;2-6  0.286
2010 Roberts RA, Smith RA, Safe S, Szabo C, Tjalkens RB, Robertson FM. Toxicological and pathophysiological roles of reactive oxygen and nitrogen species. Toxicology. 276: 85-94. PMID 20643181 DOI: 10.1016/J.Tox.2010.07.009  0.278
2009 Debeb B, Hall C, Xu W, Ueno N, Reuben J, Robertson F, Lucci A, Buchholz T, Hortobagyi G, Cristofanilli M, Woodward W. Populations of cells exhibiting epithelial-mesenchymal transition (EMT) or stem cell characteristics can be propagated from a single inflammatory breast cancer (IBC) cell line based on culture conditions. Cancer Research. 69: 103. DOI: 10.1158/0008-5472.Sabcs-103  0.276
2001 Shokolenko I, Oberyszyn TM, D'Ambrosio SM, Saavedra JE, Keefer LK, LeDoux SP, Wilson GL, Robertson FM. Protection of human keratinocyte mtDNA by low-level nitric oxide. Nitric Oxide : Biology and Chemistry / Official Journal of the Nitric Oxide Society. 5: 555-60. PMID 11730362 DOI: 10.1006/Niox.2001.0381  0.269
2004 Affara NI, Schanbacher BL, Mihm MJ, Cook AC, Pei P, Mallery SR, Trempus CS, Bauer JA, Robertson FM. Activated Akt-1 in specific cell populations during multi-stage skin carcinogenesis. Anticancer Research. 24: 2773-81. PMID 15517884  0.259
2007 Pope-Harman A, Cheng MM, Robertson F, Sakamoto J, Ferrari M. Biomedical nanotechnology for cancer. The Medical Clinics of North America. 91: 899-927. PMID 17826110 DOI: 10.1016/J.Mcna.2007.05.008  0.257
2004 Affara NI, Robertson FM. Vascular endothelial growth factor as a survival factor in tumor-associated angiogenesis. In Vivo (Athens, Greece). 18: 525-42. PMID 15523889  0.248
2013 Robertson FM, Chu K, Fernandez SV, Ye Z, Barsky SH, Cristofanilli M. Gene signatures of inflammatory breast cancer: Epithelial plasticity and a cancer stem cell phenotype Cell and Molecular Biology of Breast Cancer. 305-322. DOI: 10.1007/978-1-62703-634-4_14  0.246
2008 Tasciotti E, Liu X, Bhavane R, Plant K, Leonard AD, Price BK, Cheng MM, Decuzzi P, Tour JM, Robertson F, Ferrari M. Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. Nature Nanotechnology. 3: 151-7. PMID 18654487 DOI: 10.1038/Nnano.2008.34  0.245
1994 l N, Oberyszyn TM, Oberyszyn AS, Boros LG, Robertson FM. 148; DIFFERENTIAL MODULATION OF PULMONARY IL-1-?? GENE EXPRESSION BY PENTOXYFYLLINE IN RESPONSE TO ENDOTOXIN IN C3H/HEN ENDOTOXIN SENSITIVE, and C3H/HEJ ENDOTOXIN RESISTANT MICE Shock. 1: 41. DOI: 10.1097/00024382-199401001-00149  0.243
2003 Wilson RF, Morse MA, Pei P, Renner RJ, Schuller DE, Robertson FM, Mallery SR. Endostatin inhibits migration and invasion of head and neck squamous cell carcinoma cells. Anticancer Research. 23: 1289-95. PMID 12820385  0.243
2009 Robertson FM. Oxidative and nitrative stress in multi-stage skin carcinogenesis Toxicology Letters. 189: S23. DOI: 10.1016/J.Toxlet.2009.06.030  0.238
1992 Gilmour SK, Robertson FM, Megosh L, O'Connell SM, Mitchell J, O'Brien TG. Induction of ornithine decarboxylase in specific subpopulations of murine epidermal cells following multiple exposures to 12-O-tetradecanoylphorbol-13-acetate, mezerein and ethyl phenylpropriolate. Carcinogenesis. 13: 51-6. PMID 1733573 DOI: 10.1093/carcin/13.1.51  0.236
2001 Oberyszyn AS, Robertson FM. Novel rapid method for visualization of extent and location of aerosol contamination during high-speed sorting of potentially biohazardous samples. Cytometry. 43: 217-22. PMID 11170110 DOI: 10.1002/1097-0320(20010301)43:3<217::Aid-Cyto1053>3.0.Co;2-J  0.231
1991 Sirak AA, Beavis AJ, Robertson FM. Enhanced hydroperoxide production by peripheral blood leukocytes following exposure of murine epidermis to 12-O-tetradecanoylphorbol-13-acetate. Carcinogenesis. 12: 91-5. PMID 1988187 DOI: 10.1093/carcin/12.1.91  0.226
2012 Barsky SH, Robertson FM. Pathology: Histomorphometrical features of IBC – angiogenesis, lymphangiogenesis, and tumor emboli Inflammatory Breast Cancer: An Update. 27-51. DOI: 10.1007/978-94-007-3907-9_5  0.224
1990 Sirak AA, Laskin JD, Robertson FM, Laskin DL. Failure of F-Met-Leu-Phe to induce chemotaxis in differentiated promyelocytic (HL-60) leukemia cells. Journal of Leukocyte Biology. 48: 333-42. PMID 2168465 DOI: 10.1002/Jlb.48.4.333  0.22
2014 Baptista-Hon DT, Robertson FM, Robertson GB, Owen SJ, Rogers GW, Lydon EL, Lee NH, Hales TG. Potent inhibition by ropivacaine of metastatic colon cancer SW620 cell invasion and NaV1.5 channel function. British Journal of Anaesthesia. 113: i39-i48. PMID 24852501 DOI: 10.1093/Bja/Aeu104  0.217
2022 Rypens C, Bertucci F, Finetti P, Robertson F, Fernandez SV, Ueno N, Woodward WA, Van Golen K, Vermeulen P, Dirix L, Viens P, Birnbaum D, Devi GR, Cristofanilli M, Van Laere S. Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC. Npj Breast Cancer. 8: 12. PMID 35042871 DOI: 10.1038/s41523-021-00379-6  0.215
1988 Laskin DL, Robertson FM, Pilaro AM, Laskin JD. Activation of liver macrophages following phenobarbital treatment of rats. Hepatology (Baltimore, Md.). 8: 1051-5. PMID 2971014 DOI: 10.1002/Hep.1840080512  0.214
1990 Robertson FM, Gilmour SK, Conney AH, Huang MT, Beavis AJ, Laskin JD, Hietala OA, O'Brien TG. Identification of epidermal cell subpopulations with increased ornithine decarboxylase activity following treatment of murine epidermis with 12-O-tetradecanoylphorbol-13-acetate. Cancer Research. 50: 4741-6. PMID 2369749  0.21
2011 Roberts RA, Smith RA, Safe S, Szabo C, Tjalkens RB, Robertson FM. Erratum to “Toxicological and pathophysiological roles of reactive oxygen and nitrogen species” [Toxicology 276 (2010) 85–94] Toxicology. 279: 208. DOI: 10.1016/J.Tox.2010.09.008  0.197
2006 Affara NI, Trempus CS, Schanbacher BL, Pei P, Mallery SR, Bauer JA, Robertson FM. Activation of Akt and mTOR in CD34+/K15+ keratinocyte stem cells and skin tumors during multi-stage mouse skin carcinogenesis. Anticancer Research. 26: 2805-20. PMID 16886599  0.197
1993 Das KM, Squillante L, Robertson FM. Amplified expression of intercellular adhesion molecule-1 (ICAM-1) and M(r) 40K protein by DLD-1 colon tumor cells by interferon-gamma. Cellular Immunology. 147: 215-21. PMID 8096438 DOI: 10.1006/cimm.1993.1061  0.183
1990 Robertson FM, Gilmour SK, Beavis AJ, O'Connell SM, Conney AH, Huang MT, Laskin JD, Hietala OA, O'Brien TG. Flow cytometric detection of ornithine decarboxylase activity in epidermal cell subpopulations. Cytometry. 11: 832-6. PMID 2272247 DOI: 10.1002/Cyto.990110709  0.178
1993 Quintavalla JC, Berg RA, Beavis AJ, Piccoli SP, Rediske JJ, Kurkinen M, Patrick RA, Robertson FM. Differential induction of stromelysin mRNA by bovine articular chondrocytes treated with interferon-gamma and interleukin-1 alpha. Journal of Cellular Physiology. 154: 113-21. PMID 8419398 DOI: 10.1002/jcp.1041540114  0.176
1990 Robertson FM, Beavis AJ, Oberyszyn TM, O'Connell SM, Dokidos A, Laskin DL, Laskin JD, Reiners JJ. Production of hydrogen peroxide by murine epidermal keratinocytes following treatment with the tumor promoter 12-O-tetradecanoylphorbol-13-acetate. Cancer Research. 50: 6062-7. PMID 2393871  0.172
1992 Das KM, Squillante L, Robertson F. Expression of the 40 kD protein in DLD-1 colon cancer cells and the effect of cytokines. Clinical and Experimental Immunology. 88: 138-42. PMID 1373349 DOI: 10.1111/j.1365-2249.1992.tb03053.x  0.168
1993 Krause TJ, Robertson FM, Greco RS. Measurement of intracellular hydrogen peroxide induced by biomaterials implanted in a rodent air pouch. Journal of Biomedical Materials Research. 27: 65-9. PMID 8421000 DOI: 10.1002/jbm.820270109  0.164
1995 Oberyszyn TM, Sauder DN, Long BW, Robertson FM. Interleukin-1α as a biomarker for the epidermal response to mononuclear cell-derived cytokines and inflammatory stimuli In Vitro Toxicology: Journal of Molecular and Cellular Toxicology. 8: 437-451.  0.149
1990 Tiku ML, Liesch JB, Robertson FM. Production of hydrogen peroxide by rabbit articular chondrocytes. Enhancement by cytokines. Journal of Immunology (Baltimore, Md. : 1950). 145: 690-6. PMID 2114447  0.146
1990 Krause TJ, Robertson FM, Liesch JB, Wasserman AJ, Greco RS. Differential production of interleukin 1 on the surface of biomaterials. Archives of Surgery (Chicago, Ill. : 1960). 125: 1158-60. PMID 2400309 DOI: 10.1001/archsurg.1990.01410210084013  0.141
1990 Margiotta MS, Robertson FM, Greco RS. Selective induction of intercellular adhesion molecule expression by human endothelial cells after adherence to vascular grafts Surgical Forum. 41: 339-341.  0.139
1991 Devereux DF, O'Connell SM, Spain DA, Robertson FM. Peritoneal leukocyte response following placement of polyglycolic acid intestinal sling in patients with rectal carcinoma. Diseases of the Colon and Rectum. 34: 670-4. PMID 1649736 DOI: 10.1007/BF02050348  0.134
1987 Ebert EC, Roberts AI, O'Connell SM, Robertson FM, Nagase H. Characterization of an immunosuppressive factor derived from colon cancer cells. Journal of Immunology (Baltimore, Md. : 1950). 138: 2161-8. PMID 3104453  0.125
1990 Robertson FM, Romanow J, Otchy DP, Walters MJ. Effect of mass screening mammography on staging of carcinoma of the breast in women. Surgery, Gynecology & Obstetrics. 171: 55-8. PMID 2360150  0.122
1991 Devereux DF, O'Connell SM, Liesch JB, Weinstein M, Robertson FM. Induction of leukocyte activation by meshes surgically implanted in the peritoneal cavity. American Journal of Surgery. 162: 243-6. PMID 1656806 DOI: 10.1016/0002-9610(91)90078-R  0.119
1994 Robertson FM, Offner PJ, Ciceri DP, Becker WK, Pruitt BA. Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock. Archives of Surgery (Chicago, Ill. : 1960). 129: 149-55; discussion 1. PMID 7508219 DOI: 10.1001/Archsurg.1994.01420260045005  0.114
1993 Kalambakas SA, Robertson FM, O'Connell SM, Sinha S, Vishnupad K, Karp GI. Adenosine diphosphate stimulation of cultured hematopoietic cell lines. Blood. 81: 2652-7. PMID 8490174  0.109
2010 Robertson FM. High-Content Analysis--CHI's Seventh Annual Conference--Developments in HCA and Pathway Analysis. Idrugs : the Investigational Drugs Journal. 13: 149-52. PMID 20191427  0.093
1997 Robertson FM, Jacir NN, Crombleholme TM, Moriarty KP, Verhave M. Thoracoscopic esophagomyotomy for achalasia in a child. Journal of Pediatric Gastroenterology and Nutrition. 24: 215-7. PMID 9106110 DOI: 10.1097/00005176-199702000-00017  0.092
2008 Tasciotti E, Robertson FM, Ferrari M. Nanoporous Silicon as a Platform for Targeted Drug Delivery and Discovery of Proteomic Signatures for Cancer Diagnostics Aacr Education Book. 2008: 679-685. DOI: 10.1158/AACR.EDB-08-8140  0.092
1995 Offner PJ, Robertson FM, Pruitt BA. Effects of nitric oxide synthase inhibition on regional blood flow in a porcine model of endotoxic shock. The Journal of Trauma. 39: 338-43. PMID 7545764 DOI: 10.1097/00005373-199508000-00025  0.09
1991 Laskin DL, Sirak AA, Robertson FM, Laskin JD. Distinct patterns of chemotactic peptide-induced calcium mobilization in differentiated myeloid leukemia cells and peripheral blood neutrophils. Journal of Leukocyte Biology. 49: 369-79. PMID 1848272 DOI: 10.1002/Jlb.49.4.369  0.084
1996 Jacir NN, Robertson FM, Crombleholme TM, Harris BH. Recurrence of immune thrombocytopenic purpura after splenectomy. Journal of Pediatric Surgery. 31: 115-6. PMID 8632261 DOI: 10.1016/S0022-3468(96)90331-0  0.064
1996 Moriarty KP, Jacir NN, Harris BH, Latchaw LA, Robertson FM, Crombleholme TM. Transanastomotic feeding tubes in repair of esophageal atresia. Journal of Pediatric Surgery. 31: 53-4; discussion 54-. PMID 8632286 DOI: 10.1016/S0022-3468(96)90318-8  0.063
1993 Robertson FM, Olsen SB, Jackson MR, Rochon RB. Inguinal-scrotal suppuration following treatment of perforated appendicitis. Journal of Pediatric Surgery. 28: 267-8. PMID 8437094 DOI: 10.1016/S0022-3468(05)80292-1  0.063
1992 Jackson MR, Olson DW, Beckett WC, Olsen SB, Robertson FM. Abdominal vascular trauma: a review of 106 injuries. The American Surgeon. 58: 622-6. PMID 1416435  0.056
1992 Robertson FM, Wheeler R, Olsen SB, Jackson MR. Dapsone hepatitis following treatment of a brown recluse spider bite Infections in Medicine. 9: 52-54.  0.054
2009 Robertson FM. High-content analysis - CHI's seventh annual conference: Developments in HCA and pathway analysis Surface Review and Letters. 16: 149-152.  0.049
1996 Robertson FM, Cendron M, Klauber GT, Harris BH. Renal cell carcinoma in association with tuberous sclerosis in children. Journal of Pediatric Surgery. 31: 729-30. PMID 8861495 DOI: 10.1016/S0022-3468(96)90689-2  0.048
1995 Robertson FM, Crombleholme TM, Frantz ID, Shephard BA, Bianchi DW, D'Alton ME. Devascularization and staged resection of giant sacrococcygeal teratoma in the premature infant. Journal of Pediatric Surgery. 30: 309-11. PMID 7738756 DOI: 10.1016/0022-3468(95)90579-0  0.044
1994 Robertson FM, Crombleholme TM, Paidas M, Harris BH. Prenatal diagnosis and management of gastrointestinal anomalies. Seminars in Perinatology. 18: 182-95. PMID 7973786  0.037
1998 Suresh S, Cohen IJ, Matuszczak M, Schreiner M, Weldon BC, Davis PJ, Bikhazi GB, Robertson FM, Karl HW, Hummer K, Hannallah RS, Szmuk P, Khoo K, Collins P, Cote CJ. DOSE RANGING, SAFETY, AND EFFICACY OF A NEW ORAL MIDAZOLAM SYRUP IN CHILDREN Anesthesiology. 89: 1313A. DOI: 10.1097/00000542-199809210-00069  0.034
1985 Stephens GA, Robertson FM. Renal responses to diuretics in the turtle. Journal of Comparative Physiology. B, Biochemical, Systemic, and Environmental Physiology. 155: 387-93. PMID 3915502 DOI: 10.1007/BF00687483  0.033
1992 Neville RG, Bryce FP, Robertson FM, Crombie IK, Clark RA. Diagnosis and treatment of asthma in children: usefulness of a review of medical records. The British Journal of General Practice : the Journal of the Royal College of General Practitioners. 42: 501-3. PMID 1297369  0.033
1981 Robertson FM, Stephens GA, Creekmore JS. Renal responses to diuretics in the freshwater turtle Pseudemys scripta elegans Federation Proceedings. 40: No. 1392.  0.031
2005 Yerkes EB, Robertson FM, Gitlin J, Kaefer M, Cain MP, Rink RC. Management of perinatal torsion: today, tomorrow or never? The Journal of Urology. 174: 1579-82; discussion . PMID 16148656 DOI: 10.1097/01.ju.0000179542.05953.11  0.029
1994 Paidas MJ, Crombleholme TM, Robertson FM. Prenatal diagnosis and management of the fetus with an abdominal wall defect. Seminars in Perinatology. 18: 196-214. PMID 7973787  0.026
1986 Agarwal BN, Robertson FM. Metabolic alkalosis and hypermagnesemia following "non-absorbable" antacid therapy. Delaware Medical Journal. 58: 531-2. PMID 3758433  0.026
1985 Paton RM, Robertson FM, Ross JF, Crosby J. Nitrile sulphides. Part 3. Thermal fragmentation of 1,3,4-oxathiazoles: Formation of nitrile sulphides in a retro-1,3-dipolar cycloaddition reaction Journal of the Chemical Society, Perkin Transactions 1. 1517-1521.  0.022
1994 Olsen SB, Watts MM, LaNeve RJ, Jackson MR, Robertson FM. Initial experience with laparoscopic cholecystectomy at an Army community hospital. Military Medicine. 159: 306-9. PMID 20058426 DOI: 10.1093/Milmed/159.4.306  0.021
1980 Paton RM, Robertson FM, Ross JF, Crosby J. Nitrile sulphide formation from the thermal fragmentation of 1,3,4-oxathiazoles:A retro-1,3-dipolar cycloaddition Journal of the Chemical Society, Chemical Communications. 714-715.  0.02
1989 Proctor J, Phillipps C, Duff GK, Heaney A, Robertson FM. Ecological studies on Gunung Silam, a small ultrabasic mountain in Sabah, Malaysia. II. Some forest processes Journal of Ecology. 77: 317-331.  0.019
1996 Robertson FM, Crombleholme TM, Latchaw LA, Jacir NN. Modification of the "push" technique for percutaneous endoscopic gastrostomy in infants and children. Journal of the American College of Surgeons. 182: 215-8. PMID 8603240  0.014
2004 Robertson FM, Doski JJ, Cofer BR, Kidd JN. Laparoscopic splenic cystectomy: A rational approach Pediatric Endosurgery and Innovative Techniques. 8: 321-326.  0.01
2000 York GB, Robertson FM, Cofer BR, Bomalaski MD, Lynch SC. Laparoscopic nephrectomy in children. Surgical Endoscopy. 14: 469-72. PMID 10858474 DOI: 10.1007/S004640000081  0.01
1996 Robertson FM, Crombleholme TM, Barlow SE, Verhave M, Brown D. Ceftriaxone choledocholithiasis. Pediatrics. 98: 133-5. PMID 8668387  0.01
1994 Olsen SB, Behrens JJ, Enzler MJ, Robertson FM, Weisbrod HG. Tuberculosis of the clavicle Infections in Medicine. 11: 664-668.  0.01
1981 Robertson FM, Stephens GA. A cloacal catheter for accurate collection of urine in turtles Comparative Biochemistry and Physiology -- Part a: Physiology. 70: 653-654. DOI: 10.1016/0300-9629(81)92595-0  0.01
1855 Robertson FM. Art. X.—Strangulated Inguinal Hernia, the Testicle on the ruptured side never having descended from the Pelvis; Operation; Cure. The American Journal of the Medical Sciences. 27: 127-129. DOI: 10.1097/00000441-185527570-00010  0.01
1854 ROBERTSON FM. Art. XIII.— Removal of the Astragalus. The American Journal of the Medical Sciences. 20: 414-417. DOI: 10.1097/00000441-185420540-00013  0.01
Hide low-probability matches.